WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CERULEAN wurde als Wortmarke am 25.06.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1169414 |
| Länder | 
|
| Basismarke |
Nr. ,
27. August 2024
|
| Anmeldedatum | 25. Juni 2013 |
| Ablaufdatum | 25. Juni 2023 |
Markeninhaber
840 Memorial Drive, 5th Floor
Cambridge, MA 02139
US
Cambridge, MA 02139
US
Markenvertreter
4 Times Square,
New York NY 10036
US
Waren und Dienstleistungen
01
Diagnostic and prognostic preparations for clinical or
medical laboratory use; diagnostic and prognostic reagents
for identifying a disease or disorder and/or the progression
of a disease or disorder
05
Pharmaceutical preparations for use in the treatment of
oncological diseases or disorders, including malignant
cancers or neoplasms; pharmaceutical preparations for use in
chemotherapy; pharmaceutical preparations for use in the
treatment of oncological diseases or disorders, including
malignant cancers or neoplasms; pharmaceutical preparations
for use in chemotherapy; pharmaceutical preparations for use
in the treatment of oncological diseases or disorders,
including malignant cancers or neoplasms, all containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient; pharmaceutical
preparations for use in chemotherapy, containing nanometer
size compounds which facilitate targeting or delivery of the
active ingredient; pharmaceutical preparations for use in
the diagnosis, prognosis or prevention of oncological
diseases or disorders, including malignant cancers or
neoplasms; pharmaceutical preparations for use in the
diagnosis, prognosis, prevention or treatment of oncological
diseases or disorders, including pre-cancerous diseases or
disorders and benign cancers or neoplasms, inflammation and
inflammatory diseases or disorders, and cardiovascular
diseases or disorders; pharmaceutical preparations for use
in modulating angiogenesis; pharmaceutical preparations for
use in the diagnosis, prognosis and prevention of
oncological diseases or disorders, including malignant
cancers or neoplasms, all containing nanometer size
compounds which facilitate targeting or delivery of the
active ingredient; pharmaceutical preparations for use in
the diagnosis, prognosis, prevention or treatment of
oncological diseases or disorders, including pre-cancerous
diseases or disorders and benign cancers or neoplasms,
inflammation and inflammatory diseases or disorders, and
cardiovascular diseases or disorders, all containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient; pharmaceutical
preparations for use in modulating angiogenesis, containing
nanometer size compounds which facilitate targeting or
delivery of the active ingredient
42
Medical and scientific research services, namely, research,
development, analytical, formulation, and product
development services in the pharmaceutical field
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 09. Mai 2019 | 2019/27 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| 14. Oktober 2016 | 2017/26 Gaz | US | RAW: Partial Ceasing Effect |
| 29. Oktober 2014 | 2014/47 Gaz | CN | Ablehnung |
| 25. Juni 2013 | 2013/29 Gaz | US | Eintragung |
ID: 141169414